Literature DB >> 23649296

Two new drugs for homozygous familial hypercholesterolemia: managing benefits and risks in a rare disorder.

Robert J Smith1, William R Hiatt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649296     DOI: 10.1001/jamainternmed.2013.6624

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

Review 1.  Novel therapies for treating familial hypercholesterolemia.

Authors:  Salman J Bandeali; Jad Daye; Salim S Virani
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

2.  Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma.

Authors:  Yi Hu; Huimin Liu; Chuanfeng Fang; Chen Li; Fjorela Xhyliu; Hayley Dysert; Juraj Bodo; Gabriel Habermehl; Benjamin E Russell; Wenjun Li; Marcia Chappell; Xiaofeng Jiang; Sarah L Ondrejka; Eric D Hsi; Jaroslaw P Maciejewski; Qing Yi; Kenneth C Anderson; Nikhil C Munshi; Geyou Ao; Jason N Valent; Jianhong Lin; Jianjun Zhao
Journal:  Cancer Res       Date:  2020-03-19       Impact factor: 12.701

Review 3.  Bioengineering of noncoding RNAs for research agents and therapeutics.

Authors:  Pui Yan Ho; Ai-Ming Yu
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-01-13       Impact factor: 9.957

Review 4.  In vivo gene delivery mediated by non-viral vectors for cancer therapy.

Authors:  Reza Mohammadinejad; Ali Dehshahri; Vijay Sagar Madamsetty; Masoumeh Zahmatkeshan; Shima Tavakol; Pooyan Makvandi; Danial Khorsandi; Abbas Pardakhty; Milad Ashrafizadeh; Elham Ghasemipour Afshar; Ali Zarrabi
Journal:  J Control Release       Date:  2020-07-04       Impact factor: 9.776

5.  Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.

Authors:  Yi Hu; Jianhong Lin; Hua Fang; Jing Fang; Chen Li; Wei Chen; Shuang Liu; Sarah Ondrejka; Zihua Gong; Frederic Reu; Jaroslaw Maciejewski; Qing Yi; Jian-Jun Zhao
Journal:  Leukemia       Date:  2018-03-22       Impact factor: 11.528

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.